Agreements reached under this partnership
Capital and Business Alliance- 1
By combining their respective capabilities, the two companies intend to jointly explore new problem-solving solutions that combine pharmaceuticals and drones across a wide range of fields, including agriculture, wildlife damage control, disaster prevention and infrastructure inspection.
- 2
The companies will jointly promote a new solutions business combining 昭栄薬品’s functional products and drone technology.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this alliance on business performance is expected to be minor, but the companies believe it will contribute to enhancing corporate value over the medium to long term. If any matters requiring disclosure arise, they will be announced promptly.
| Item | Details |
|---|---|
| Name of alliance partner | 株式会社エアロネクスト |
| Alliance partner's business activities | Joint development and licensing businesses with major companies and others centered on the 4D GRAVITY® center-of-gravity control technology, as well as the SkyHub® business and drone operations business conducted through its subsidiary NEXT DELIVERY |
| Alliance partner's location | Shibuya, Tokyo |
| Type of alliance | Capital and Business Alliance |
| Details of the alliance | By combining their respective capabilities, the two companies intend to jointly explore new problem-solving solutions that combine pharmaceuticals and drones across a wide range of fields, including agriculture, wildlife damage control, disaster prevention and infrastructure inspection., The companies will jointly promote a new solutions business combining 昭栄薬品’s functional products and drone technology. |
| Date of board resolution | 28 August 2026 |
| Contract Date | 28 August 2026 |
| Impact on Business Performance | The impact of this alliance on business performance is expected to be minor, but the companies believe it will contribute to enhancing corporate value over the medium to long term. If any matters requiring disclosure arise, they will be announced promptly. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The companies aim to promote joint businesses from a medium- to long-term perspective and create new markets while enhancing the added value of existing businesses by combining 昭栄薬品’s customer base, products and specialized knowledge of chemicals with エアロネクスト’s drone platform.